Autopsy report · NCT00396240

ORBITAL: Open-Label Primary Care Study: Rosuvastatin Based Compliance Initiatives Linked To Achievement Of LDL Goals

Cause of deathOther Automatic label, confidence 0.3, unverified. How labels are made.

“study cancelled prior to FSI”

The sponsor’s own words in the registry.

Life of this trial

Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status: Withdrawn
Phase: Phase 4
Sponsor: AstraZeneca
Sponsor type: Industry
Conditions: Primary Hypercholesterolaemia
Interventions: Rosuvastatin; Initiatives to improve compliance
Participants: 1,294

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.